Subtitle
Development of advanced preselection tools to reduce redundant plan comparisons in model-based selection of head and neck cancer patients for proton therapy.
Using data from VMAT plans and volumetric data from delineated targets and OARs, the researchers developed the advanced preselection tools that prevented labor intensive creation of IMPT plans in up to 68% of non-qualifying patients for PT, and no false negative cases, i.e. no patients qualifying for PT would have been incorrectly denied a plan comparison.